Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Leukemia

  Free Subscription


28.04.2020

2 Acta Haematol
1 Am J Clin Pathol
2 Am J Hematol
4 Ann Hematol
1 Biochem Biophys Res Commun
4 Blood
3 Br J Haematol
1 J Clin Oncol
2 J Pediatr Hematol Oncol
1 Leuk Lymphoma
1 Leuk Res
3 Leukemia
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. RAANANI P, Sharf G
    Interview with a Patients' Advocate.
    Acta Haematol. 2020;143:1-4.
    PubMed        

  2. KUAN JW, Su AT, Leong CF, Osato M, et al
    Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene.
    Acta Haematol. 2020;143:96-111.
    PubMed         Abstract available


    Am J Clin Pathol

  3. SCHUMACHER JA, Holgard VD, Sial F, Pearson LN, et al
    Detection and Quantification of FLT3 Internal Tandem Duplication Mutations Do Not Vary Significantly Between Whole Blood and Blast-Enriched Samples.
    Am J Clin Pathol. 2020;153:251-257.
    PubMed         Abstract available


    Am J Hematol

  4. CADENAS FL, Bua BR, Campelo MD, Rieu JB, et al
    A myeloid neoplasm with FIP1L1-PDGFRA presenting as acute myeloid leukemia.
    Am J Hematol. 2020 Apr 20. doi: 10.1002/ajh.25842.
    PubMed        

  5. CHRISTIAN S, Arain S, Patel P, Khan I, et al
    A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
    Am J Hematol. 2020 Apr 20. doi: 10.1002/ajh.25838.
    PubMed         Abstract available


    Ann Hematol

  6. GAO M, Zhao X
    Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia.
    Ann Hematol. 2020 Apr 19. pii: 10.1007/s00277-020-04037.
    PubMed        

  7. BRUMMENDORF TH, Gambacorti-Passerini C, Bushmakin AG, Cappelleri JC, et al
    Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia.
    Ann Hematol. 2020 Apr 19. pii: 10.1007/s00277-020-04018.
    PubMed         Abstract available

  8. HORISAWA Y, Kondo T, Hishizawa M, Yamashita K, et al
    A case of allogeneic hematopoietic stem cell transplantation for primary plasma cell leukemia after treatment with daratumumab.
    Ann Hematol. 2020 Apr 21. pii: 10.1007/s00277-020-04029.
    PubMed        

  9. HELBIG G, Koclega A, Wieczorkiewicz-Kabut A, Wozniczka K, et al
    Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation.
    Ann Hematol. 2020 Apr 24. pii: 10.1007/s00277-020-04026.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  10. DAHLSTROM J, Xia C, Xing X, Yuan X, et al
    JAK2 inhibition in JAK2(V617F)-bearing leukemia cells enriches CD34(+) leukemic stem cells that are abolished by the telomerase inhibitor GRN163L.
    Biochem Biophys Res Commun. 2020 Apr 22. pii: S0006-291X(20)30779.
    PubMed         Abstract available


    Blood

  11. ENSHAEI A, O'Connor D, Bartram J, Hancock J, et al
    A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
    Blood. 2020;135:1438-1446.
    PubMed         Abstract available

  12. LONG J, Jia MY, Fang WY, Chen XJ, et al
    FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.
    Blood. 2020;135:1472-1483.
    PubMed         Abstract available

  13. DE SMEDT R, Morscio J, Reunes L, Roels J, et al
    Targeting cytokine and therapy induced PIM1 activation in T-cell acute lymphoblastic leukemia and lymphoma.
    Blood. 2020 Feb 13. pii: 452489. doi: 10.1182/blood.2019003880.
    PubMed         Abstract available

  14. ORVAIN C, Balsat M, Tavernier E, Marolleau JP, et al
    Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study.
    Blood. 2020 Apr 22. pii: 454452. doi: 10.1182/blood.2020004919.
    PubMed         Abstract available


    Br J Haematol

  15. FUSTER JL, Molinos-Quintana A, Fuentes C, Fernandez JM, et al
    Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP).
    Br J Haematol. 2020 Apr 21. doi: 10.1111/bjh.16647.
    PubMed         Abstract available

  16. SU C, Bai HX, Xiao R
    HTLV-1 status should be recorded in cases of T cell lymphomas/lymphoproliferative disorders - cases of adult T cell leukaemia lymphoma masquerading as other T cell lymphomas/lymphoproliferative disorders could explain some of the apparent ethnic dispa
    Br J Haematol. 2018 Aug 3. doi: 10.1111/bjh.15526.
    PubMed        

  17. LO BELLO G, Naresh KN
    HTLV-1 status should be recorded in cases of T cell lymphomas/lymphoproliferative disorders - cases of adult T cell leukaemia lymphoma masquerading as other T cell lymphomas/lymphoproliferative disorders could explain some apparent ethnic disparities.
    Br J Haematol. 2018 Aug 3. doi: 10.1111/bjh.15527.
    PubMed        


    J Clin Oncol

  18. LADAS EJ, Blonquist TM, Puligandla M, Orjuela M, et al
    Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort.
    J Clin Oncol. 2020 Apr 24:JCO1902555. doi: 10.1200/JCO.19.02555.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  19. DANESHDOOST SM, El Abiad JM, Ruble KJ, Jones LC, et al
    Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review.
    J Pediatr Hematol Oncol. 2020 Apr 21. doi: 10.1097/MPH.0000000000001793.
    PubMed         Abstract available

  20. GRANADOS-ZAMORA M, Chaves-Herrera K, Morera-Araya E, Granados-Alfaro P, et al
    IKZF1 Deletions as a Prognostic Factor in Costa Rican Patients With Pediatric B-Cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2020 Apr 21. doi: 10.1097/MPH.0000000000001807.
    PubMed         Abstract available


    Leuk Lymphoma

  21. THOMPSON ER, Lim KJC, Kuzich JA, McBean M, et al
    Detection of an IGH-BRAF fusion in a patient with BRAF Val600Glu negative hairy cell leukemia.
    Leuk Lymphoma. 2020 Apr 22:1-3. doi: 10.1080/10428194.2020.1753045.
    PubMed        


    Leuk Res

  22. DRUHAN LJ, Lance A, Hamilton A, Steuerwald NM, et al
    Altered splicing and intronic polyadenylation of CSF3R via a cryptic exon in acute myeloid leukemia.
    Leuk Res. 2020;92:106349.
    PubMed        


    Leukemia

  23. DHAKAL B, Patel S, Girnius S, Bachegowda L, et al
    Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
    Leukemia. 2020 Apr 20. pii: 10.1038/s41375-020-0830.
    PubMed         Abstract available

  24. TOMLINSON CG, Sasa G, Aubert G, Martin-Giacalone B, et al
    Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome.
    Leukemia. 2020 Apr 21. pii: 10.1038/s41375-020-0835.
    PubMed        

  25. WAKAMATSU M, Okuno Y, Murakami N, Miwata S, et al
    Detection of subclonal SETBP1 and JAK3 mutations in juvenile myelomonocytic leukemia using droplet digital PCR.
    Leukemia. 2020 Apr 20. pii: 10.1038/s41375-020-0817.
    PubMed        


    Oncol Rep

  26. XIONG Q, Huang S, Li YH, Lv N, et al
    Singlecell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction.
    Oncol Rep. 2020 Feb 18. doi: 10.3892/or.2020.7507.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: